Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

23.35 +0.23 (+0.99%)
Official Closing Price Updated: 7:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30,428,987
Open 23.27
Bid (Size) 23.38 (1)
Ask (Size) 23.40 (13)
Prev. Close 23.12
Today's Range 23.25 - 23.58
52wk Range 20.91 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 7.37%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Should You Buy Pfizer Stock Right Now?
Via The Motley Fool
Exposures COVID-19
Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approval
Arvinas and Pfizer submit NDA to FDA for vepdegestrant after Phase 3 data shows efficacy in ESR1-mutated ER+/HER2- breast cancer patients 
Via Benzinga
Exposures Product Safety

Performance

YTD
-12.3%
-12.3%
1 Month
+1.7%
+1.7%
3 Month
-12.3%
-12.3%
6 Month
-10.5%
-10.5%
1 Year
-18.3%
-18.3%

More News

Read More
RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts
Via Benzinga
Exposures COVID-19
Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
From Arvinas Inc.
Via GlobeNewswire
Pfizer's Mega Deal Highlights China's Rising Role In Global Pharma
Via Benzinga
Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis
Via The Motley Fool
Topics Intellectual Property Retirement
Exposures COVID-19 Intellectual Property Pension
Here Are All 6 Stocks I've Bought Through 5 Months of 2025
Via The Motley Fool
Topics Stocks
Exposures COVID-19 US Equities
Hundreds Sue Pfizer Over Birth Control Jabs Linked to Brain Tumors
Via Investor Brand Network
Topics Lawsuit
Exposures Financial Legal
S&P 500 Earnings Stun The Street In Q1 With Broad-Based Beats, Double-Digit Growth
Via Benzinga
Topics Stocks
Exposures US Equities
These 2 Dow Stocks Are Set to Soar in 2025 and Beyond
Via The Motley Fool
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence COVID-19 Economy
3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June
Via The Motley Fool
Why BioNTech Stock Soared Today
Via The Motley Fool
Exposures COVID-19
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
Michael McTague: Watch out for these killer superbugs that resist today’s antibiotics
Via Equities.com
Topics Death
Exposures Death
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE)
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Terrible News for Pfizer Stock Investors
Via The Motley Fool
Exposures COVID-19 Product Safety
Beat the S&P 500 With This Cash-Gushing Dividend Stock
Via The Motley Fool
Topics Artificial Intelligence Bonds Intellectual Property
Exposures Artificial Intelligence Debt Markets Intellectual Property
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
From Arvinas Inc.
Via GlobeNewswire
Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%
Via Benzinga
Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
From Pfizer Inc.
Via Business Wire
2 Large-Cap Stocks to Target This Week and 1 to Keep Off Your Radar
Via StockStory
Hearing Against Pfizer Set For 30 May In Contraceptive ‘Depo-Provera’ Multidistrict Litigation Overseen By Levin Papantonio
From Levin Papantonio
Via Business Wire
Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children
Via Benzinga
Exposures COVID-19
Is Pfizer Stock a Buy After This $1.25 Billion Investment?
Via The Motley Fool
Exposures COVID-19
Down 63%, Should You Buy the Dip on Pfizer?
Via The Motley Fool
Topics Economy Government World Trade
Exposures COVID-19 Interest Rates Political

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 23.35
When was Pfizer last traded?
The last trade of Pfizer was at 06/06/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 130.92B
How many shares of Pfizer are outstanding?
Pfizer has 131B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.